Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

156129 Press Releases
DateTitleCompany
23 Feb 17 Sleep Medicine Specialist Franklin M. Douglis, M.D. Joins Ideal Protein Medical Advisory Board Ideal Protein,
Published by
Business Wire
23 Feb 17 Wearable Tech Company Recovery Force Achieves Major Milestones Recovery Force,
Published by
Business Wire
23 Feb 17 Incyte Announces Oncology Research Alliance with the Abramson Cancer Center at the University of Pennsylvania Incyte Corporation,
Published by
Business Wire
23 Feb 17 Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments Fusion Pharmaceuticals,
Published by
Business Wire
23 Feb 17 Cynvenio and Color Partner to Offer Comprehensive Hereditary and Somatic Cancer Testing from Simple Blood Draw Cynvenio Biosystems, Inc.,
Published by
Business Wire
23 Feb 17 AVEO Announces TIVO-3 Passes The First Safety Monitoring Committee Safety Review AVEO Oncology,
Published by
Business Wire
23 Feb 17 Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments twoXAR, Inc.,
Published by
Business Wire
23 Feb 17 BioTime, Inc. to Announce Fourth Quarter and Fiscal 2016 Results on March 16, 2017 BioTime, Inc.,
Published by
Business Wire
23 Feb 17 CBT Pharmaceuticals Presents Data Demonstrating Anti-Tumor Activity of its Programmed Death-1 antibody, CBT-501, at ASCO-SITC Clinical Oncology Symposium CBT Pharmaceuticals,
Published by
Business Wire
23 Feb 17 Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S. Courtagen Life Sciences, Inc.,
Published by
Business Wire
23 Feb 17 TL Biolabs Announces $4M in Funding Led by Andreessen Horowitz TL Biolabs,
Published by
Business Wire
23 Feb 17 ERT Clinical Trial Oversight Selected by Premier Research ERT
23 Feb 17 Employers Holdings, Inc. Reports Fourth Quarter and Full Year 2016 Results and Announces a 67% Increase in the Cash Dividend Geron ,
Published by
PharmiWeb.com
23 Feb 17 Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Financial Results on March 2, 2017 Paratek Pharmaceuticals ,
Published by
PharmiWeb.com
23 Feb 17 Repligen Reports Fourth Quarter 2016 Financial Results, Provides Guidance for 2017 Repligen ,
Published by
PharmiWeb.com
23 Feb 17 Protein Microcrystals Could Offer a Better Way to Treat Osteoarthritis Cell Guidance Systems,
Published by
PharmiWeb.com
23 Feb 17 Biosensing Instrument Introduces World’s First Commercially Available Surface Plasmon Resonance Microscopy System for Membrane Protein Interactions Research Biosensing Instrument ,
Published by
PharmiWeb.com
23 Feb 17 Acceleron Pharma to Webcast Conference Call of Fourth Quarter and Year Ended 2016 Financial Results on March 1, 2017 Acceleron Pharma ,
Published by
PharmiWeb.com
23 Feb 17 Kalytera Therapeutics Announces Encouraging Results of a Phase 2a Clinical Study for the Treatment of Acute Graft versus Host Disease Kalytera Therapeutics ,
Published by
PharmiWeb.com
23 Feb 17 ImmusanT Announces Completion of Phase 1b Clinical Trial of Nexvax2® for the Treatment of Celiac Disease ImmusanT ,
Published by
PharmiWeb.com
23 Feb 17 Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer Symbiomix Therapeutics ,
Published by
PharmiWeb.com
23 Feb 17 Upon Successful Completion of Cohort 3, Cellectar Biosciences Initiates Fourth Cohort of Its Phase I Clinical Trial of CLR 131 in Multiple Myeloma Cellectar Biosciences,
Published by
PharmiWeb.com
23 Feb 17 Study Published in PAIN Reveals Nicotinamide Riboside is an Effective Tool in Relieving Chemotherapy-Induced Peripheral Neuropathy Induced by a Common Anticancer Agent ChromaDex Corporation,
Published by
PharmiWeb.com
23 Feb 17 Immune Design Receives Orphan Drug Designation for G100 Intratumoral Product Candidate Immune Design ,
Published by
PharmiWeb.com
23 Feb 17 Atreca, Inc. Presents New Preclinical Findings for Novel Cancer Immunotherapy Platform at Molecular Medicine Tri-Conference 2017 Atreca,
Published by
PharmiWeb.com
23 Feb 17 Intrexon to Announce Fourth Quarter and Full Year 2016 Financial Results on March 1st Intrexon ,
Published by
PharmiWeb.com
23 Feb 17 Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update Ironwood Pharmaceuticals ,
Published by
PharmiWeb.com
23 Feb 17 Karolinska Development - Q4 and 2016 Year-End Report - invitation to conference call and webcast Karolinska Development ,
Published by
PharmiWeb.com
23 Feb 17 Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2016 Results Presentation and Webcast Nordic Nanovector,
Published by
PharmiWeb.com
23 Feb 17 Ophthotech Corporation to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on Tuesday, February 28, 2017 Ophthotech Corporation ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.